Optimisation of Sample Preparation from Primary Mouse Tissue to Maintain RNA Integrity for Methods Examining Translational Control.

RNA integrity mRNA polysome profiling ribosome translation

Journal

Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829

Informations de publication

Date de publication:
05 Aug 2023
Historique:
received: 09 06 2023
revised: 26 07 2023
accepted: 31 07 2023
medline: 12 8 2023
pubmed: 12 8 2023
entrez: 12 8 2023
Statut: epublish

Résumé

The protein output of different mRNAs can vary by two orders of magnitude; therefore, it is critical to understand the processes that control gene expression operating at the level of translation. Translatome-wide techniques, such as polysome profiling and ribosome profiling, are key methods for determining the translation rates occurring on specific mRNAs. These techniques are now widely used in cell lines; however, they are underutilised in tissues and cancer models. Ribonuclease (RNase) expression is often found to be higher in complex primary tissues in comparison to cell lines. Methods used to preserve RNA during lysis often use denaturing conditions, which need to be avoided when maintaining the interaction and position of the ribosome with the mRNA is required. Here, we detail the cell lysis conditions that produce high-quality RNA from several different tissues covering a range of endogenous RNase expression levels. We highlight the importance of RNA integrity for accurate determination of the global translation status of the cell as determined by polysome gradients and discuss key aspects to optimise for accurate assessment of the translatome from primary mouse tissue.

Identifiants

pubmed: 37568801
pii: cancers15153985
doi: 10.3390/cancers15153985
pmc: PMC10417042
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : Cancer Research UK
ID : A29252
Pays : United Kingdom
Organisme : Cancer Research UK
ID : C48702
Pays : United Kingdom
Organisme : Cancer Research UK
ID : A27603
Pays : United Kingdom
Organisme : Cancer Research UK
ID : A29996
Pays : United Kingdom
Organisme : Cancer Research UK
ID : A25233
Pays : United Kingdom

Références

Biochemistry. 2000 Nov 28;39(47):14487-94
pubmed: 11087402
Iran J Med Sci. 2014 May;39(3):282-8
pubmed: 24850986
Int J Mol Sci. 2019 May 02;20(9):
pubmed: 31052505
Biochemistry. 1979 Nov 13;18(23):5143-9
pubmed: 497174
FEBS J. 2010 Feb;277(3):627-41
pubmed: 19968858
Prog Nucleic Acid Res Mol Biol. 2005;80:349-74
pubmed: 16164979
Prog Nucleic Acid Res Mol Biol. 1993;44:1-30
pubmed: 8434120
Nature. 2011 May 19;473(7347):337-42
pubmed: 21593866
Front Immunol. 2018 May 16;9:1012
pubmed: 29867984
Cell Mol Gastroenterol Hepatol. 2021;11(1):99-115
pubmed: 32735995
BMC Mol Biol. 2006 Jan 31;7:3
pubmed: 16448564
Crit Rev Microbiol. 2002;28(2):79-122
pubmed: 12109772
FEBS Lett. 2011 Feb 18;585(4):613-7
pubmed: 21276451
Methods Enzymol. 1987;152:227-34
pubmed: 2443795
Nat Rev Mol Cell Biol. 2021 Jul;22(7):483-504
pubmed: 33837370
Nat Protoc. 2012 Jul 26;7(8):1534-50
pubmed: 22836135
Mol Aspects Med. 2019 Dec;70:106-116
pubmed: 30902663
Nucleic Acids Res. 2017 Jan 25;45(2):e6
pubmed: 27638886
Nucleic Acids Res. 2002 Mar 1;30(5):1169-75
pubmed: 11861908
FEBS Lett. 2010 Jun 3;584(11):2194-200
pubmed: 20388512
Cancer Cell. 2008 Dec 9;14(6):447-57
pubmed: 19061836
Int J Mol Sci. 2016 Aug 05;17(8):
pubmed: 27527162
Nucleic Acids Res. 2005 Mar 30;33(6):e56
pubmed: 15800207
Chem Rev. 1998 May 7;98(3):1045-1066
pubmed: 11848924
RNA. 2007 Mar;13(3):414-21
pubmed: 17237355
Neurochem Res. 1986 Sep;11(9):1373-8
pubmed: 3785550
Nat Methods. 2012 Jun 28;9(7):676-82
pubmed: 22743772
Cell. 2019 Nov 27;179(6):1264-1275.e13
pubmed: 31778653
Trends Cell Biol. 2020 Aug;30(8):606-618
pubmed: 32461030
Nat Genet. 2003 Dec;35(4):292-3
pubmed: 14647279
Front Immunol. 2019 Nov 26;10:2626
pubmed: 31849926
Anal Biochem. 2016 May 1;500:60-2
pubmed: 26896683
Methods Mol Biol. 2016;1358:99-108
pubmed: 26463379
Nat Chem Biol. 2010 Mar;6(3):209-217
pubmed: 20118940
Stem Cell Res. 2013 Sep;11(2):902-12
pubmed: 23845413
Am J Physiol. 1956 Feb;184(2):415-7
pubmed: 13302436
Proc Natl Acad Sci U S A. 2003 Apr 1;100(7):3889-94
pubmed: 12660367
Circ Res. 2019 Aug 2;125(4):431-448
pubmed: 31284834
J Mol Biol. 2014 Aug 26;426(17):3041-56
pubmed: 24941155
Glycoconj J. 1992 Apr;9(2):86-91
pubmed: 1344713
RNA Biol. 2017 Feb;14(2):171-178
pubmed: 28010172
Mol Autism. 2020 Oct 14;11(1):78
pubmed: 33054857
Methods Mol Biol. 2011;703:293-309
pubmed: 21125498
Biotechniques. 2012 May;52(5):332-4
pubmed: 22578126
Nucleic Acids Res. 2020 Feb 20;48(3):1043-1055
pubmed: 31598688
Biochem Biophys Rep. 2016 Sep 23;8:261-267
pubmed: 28955965
Nat Rev Mol Cell Biol. 2015 Apr;16(4):221-31
pubmed: 25735911
Nature. 1977 Mar 17;266(5599):235-9
pubmed: 557727
Genes (Basel). 2022 May 14;13(5):
pubmed: 35627265
Anal Biochem. 1984 Jan;136(1):48-64
pubmed: 6201087
Proc Natl Acad Sci U S A. 2019 Jul 23;116(30):15023-15032
pubmed: 31292258
RNA. 2018 Aug;24(8):1018-1027
pubmed: 29748193
Sci Data. 2017 Dec 12;4:170185
pubmed: 29231921
Cell Rep. 2017 Oct 24;21(4):953-965
pubmed: 29069603
Genes Dev. 2001 Dec 15;15(24):3243-8
pubmed: 11751630
J Vis Exp. 2014 Aug 02;(90):e51779
pubmed: 25145327
FEBS Lett. 1992 Aug 3;307(3):343-6
pubmed: 1322837
Biochim Biophys Acta. 2016 Dec;1863(12):3125-3147
pubmed: 27713097
Genomics. 2005 Feb;85(2):208-20
pubmed: 15676279
Biochemistry. 2016 Nov 22;55(46):6359-6362
pubmed: 27806571

Auteurs

June Munro (J)

Cancer Research UK Beatson Institute, Garscube Estate, Switchback Road, Bearsden, Glasgow G61 1BD, UK.

Sarah L Gillen (SL)

Cancer Research UK Beatson Institute, Garscube Estate, Switchback Road, Bearsden, Glasgow G61 1BD, UK.

Louise Mitchell (L)

Cancer Research UK Beatson Institute, Garscube Estate, Switchback Road, Bearsden, Glasgow G61 1BD, UK.

Sarah Laing (S)

School of Cancer Sciences, University of Glasgow, Garscube Estate, Switchback Road, Bearsden, Glasgow G61 1QH, UK.

Saadia A Karim (SA)

Cancer Research UK Beatson Institute, Garscube Estate, Switchback Road, Bearsden, Glasgow G61 1BD, UK.

Curtis J Rink (CJ)

Cancer Research UK Beatson Institute, Garscube Estate, Switchback Road, Bearsden, Glasgow G61 1BD, UK.
School of Cancer Sciences, University of Glasgow, Garscube Estate, Switchback Road, Bearsden, Glasgow G61 1QH, UK.

Joseph A Waldron (JA)

Cancer Research UK Beatson Institute, Garscube Estate, Switchback Road, Bearsden, Glasgow G61 1BD, UK.

Martin Bushell (M)

Cancer Research UK Beatson Institute, Garscube Estate, Switchback Road, Bearsden, Glasgow G61 1BD, UK.
School of Cancer Sciences, University of Glasgow, Garscube Estate, Switchback Road, Bearsden, Glasgow G61 1QH, UK.

Classifications MeSH